Pt(II) Thienyl and Bithienyl Complexes
Table 4. Crystallographic Data and Refinement Details for 1, 2, 4, and 5
1a
2
4
5
empirical formula
(C38H31BrFeSPt × 0.9) +
(C34H28Br2FePt ×
0.1) + CH2Cl2
223 (2)
997.08
monoclinic
C81H65Br2Cl15-
Fe2P4Pt2S2
C
165H129Cl3F12-
Fe4 N4O24P8Pt4S4
C84H68Cl18F6-
Fe2O6P4Pt2S4
T (K)
fw
cryst syst
space group
unit cell dimensions
a (Å)
b (Å)
c (Å)
R (deg)
â (deg)
γ (deg)
V (Å3)
223 (2)
223 (2)
4265.83
triclinic
P1
223 (2)
2679.48
triclinic
P1
2419.78
monoclinic
P21/c
P21/c
22.8672 (13)
9.4384 (5)
16.4891 (10)
90
104.6670 (10)
90
3442.9 (3)
4
1.924
17.9506 (10)
17.2014 (10)
29.4006 (17)
90
97.1910 (10)
90
9006.8 (9)
4
1.784
13.081 (3)
19.233 (4)
20.302 (4)
101.189 (4)
105.355 (4)
105.829 (4)
4539.3 (15)
1
1.560
3.614
2098
0.14 × 0.08 × 0.04
-15 e h e 15,
-22 e k e 22,
-24 e l e 24
0.2245, 0.3014
0.1064, 0.2490
2.734 and -2.047
14.0474 (9)
14.3402 (9)
26.0749 (17)
99.2230 (10)
100.7800 (10)
97.7680 (10)
5018.8 (6)
Z
D
2
calcd (mg/m3)
1.773
3.748
2624
0.40 × 0.28 × 0.16
-16 e h e 16,
-17 e k e 17,
-31 e l e 31
0.0968, 0.1548
0.0673, 0.1446
2.239 and -2.846
abs coeff (mm-1
F(000)
)
6.089
1941
4.904
4704
cryst size (mm3)
index ranges
0.36 × 0.10 × 0.08
-27 e h e 27,
-11 e k e 11,
-12 e l e 19
0.0623, 0.1301
0.0505, 0.1244
2.634 and -2.055
0.30 × 0.25 × 0.20
-21 e h e 20,
-20 e k e 20
-17 e l e34
0.0617, 0.1186
0.0438, 0.1111
1.493 and -0.793
R, wR2 (all data)
final R, wR2
largest diff peak
and hole (e Å-3
)
a Compound 1 ) 0.9[PtBr(2-thienyl)(dppf)] + 0.1[PtBr2(dppf)] + CH2Cl2.
in vacuo, and Et2O was added to precipitate a yellow solid. Upon
isolation, it was washed with Et2O and dried in vacuo. Recrystal-
lization from CH2Cl2/hexane gave yellow crystals (80%). 1H
NMR: δ ) 8.0, 7.9, 7.5, 7.3, 7.2(m), 6.6(d), 6.2(t), 4.7(t), 4.5(s),
condensed and spectroscopically analyzed. 31P NMR: δ ) 19.6-
(d), 8.6(d) ppm; 1JP-Pt ) 2068, 4396 Hz. ESI: m/z ) 831.5 (100%)
1
[3 - 2MeCN]2+. A sharp singlet at 10.7 ppm, JP-P ) 4433 Hz,
and some fine peaks are observed in the 31P NMR when the solid
product was isolated and redissolved in CDCl3. The identities of
the decomposed products are not known.
2
4.1(d), 3.7(t). 31P NMR: δ ) 13.6(d), 13.2(d) JP-P ) 15.26 Hz,
1JP-Pt ) 2006.58, 4135.22 Hz. ESI: m/z ) 832.1 (100%) [1 -
Br]+. Anal. Calcd for 90% C38H31P2SBrFePt + 10% C34H28P2Br2-
FePt: C, 49.50; H, 3.39; S, 3.16. Found: C, 49.05; H, 3.31; S,
2.78.
Synthesis of Pt2Br2(dppf)2(µ2-C8H4S2), 2. 5,5′-Dibromo-2,2′-
bithiophene (0.4051 g, 1.25 mmol) was added to a solution of Pt-
(PPh3)4 (3.1104 g, 2.5 mmol) in toluene. After 15 h of reflux, a
pale yellow precipitate was obtained. Et2O was added to complete
the precipitation. Filtration gave a solid which was washed with
Et2O and dried in a vacuum to give a pale yellow solid (90%).
This solid (0.2645 g; 0.15 mmol) was added to toluene (30 mL) to
give a yellow mixture, upon which dppf (0.1663 g, 0.3 mmol) was
added. The resultant mixture was refluxed overnight to give a bright
yellow mixture, upon which Et2O was added. The precipitate was
Synthesis of [Pt4(µ2-isonic)4(dppf)4]4+4OTf-, 4. AgOTf (0.0129
g, 0.05 mmol) was dissolved in MeCN (3 mL), and CHCl3 (15
mL) was added, followed by 2 (0.0456 g, 0.025 mmol). A clear
yellow solution with an off-white precipitate formed immediately.
The mixture was stirred for 45 min and filtered. IsonicH+ (0.0062
g, 0.05 mmol) was added to the filtrate, and the mixture stirred for
5 h. A white suspension in a yellow solution was obtained. The
mixture was filtered and the filtrate condensed to ca. 3 mL. Et2O
was added to precipitate the product. Careful recrystallization in
CHCl3/hexane gave yellow triclinic crystals (64%). 31P NMR (213
2
1
K): δ ) 9.9(d), 6.6(d); JP-P ) 15.26 Hz, JP-Pt ) 3755, 3489
1
Hz. H NMR (213 K): δ ) 8.5(s) (pyridyl H), 7.8, 7.5, 7.3, 7.0-
(m) (phenyl H), 4.6, 4.5, 4.4, 4.3(s) (Cp). IR/cm-1: ν(COO)asym
,
1647, 1637; ν(COO)sym, 1342. ESI: m/z ) 871.0 (100%) (molecular
ion, M4+). Anal. Calcd for C164H128P8O20N4F12S4Fe4Pt4‚2CHCl3‚
4H2O: C, 45.75; H, 3.19; N, 1.29; S, 2.94. Found: C, 45.72; H,
3.20; N, 0.78; S, 3.43. Some chloroform as appeared in the X-ray
crystals has been lost in the process of drying the samples for
elemental analysis.
filtered, washed with Et2O and dried in vacuo to give a bright yellow
2
solid product (87%). 31P NMR: δ ) 13.6 (d), 12.7 (d), JP-P
)
1
1
15.26 Hz, JP-Pt ) 1976, 4192 Hz. H NMR: δ ) 8.1, 7.5, 7.3,
7.1(m), 6.3 (d), 5.9 (d), 4.7(s), 4.4(s), 4.1(s), 3.7(s). FAB: m/z )
1823.0 (25%) (molecular ion, M+ peak), 1743.0 (25%) [2 - Br]+,
831 (40%) [2 - 2Br]2+. Compound 2 was recrystallized in CHCl3/
hexane to give orange crystals. Anal. Calcd for C76H60P4S2Br2Fe2-
Pt2‚2CHCl3: C, 45.43; H, 3.18; S, 3.10. Found: C, 45.96; H, 3.03;
S, 3.10. Some chloroform as appeared in the X-ray crystals has
been lost in the process of drying the samples for elemental analysis.
Synthesis of [Pt2(dppf)2(µ2-C8H4S2)(MeCN)2]2+ 2OTf-, 3.
AgOTf (0.0129 g, 0.05 mmol) was dissolved in MeCN (3 mL)
shielded from light followed by the addition of acetone (15 mL).
Complex 2 (0.0456 g 0.025 mmol) was added to the solution to
give a yellow suspension. The mixture was stirred until the solution
turned clear yellow with an off-white precipitate, which was
removed by filtration over a column of Celite. The filtrate was
When 3 was reacted with potassium isonicotinate, the solution
remained yellow after overnight stirring. A yellow precipitate was
obtained when Et2O was added to the condensed solution. The solid
dissolved in acetone (a few drops) to give a swollen brown lump,
and on addition of excess acetone, a yellow solution with pale brown
gelatinous precipitate was obtained. 31P of solid product in CD3-
COCD3: δ ) 23.5(t), 20.3(t), 7.5(t), 3.1(t); 2JP-P ) 15.25 Hz, 1JP-Pt
) 2109, 2091, 4209, 3649 Hz.
Synthesis of [Pt2(dppf)2(µ2,η1(C),η1(S)-C4H3S)2]2+2OTf-, 5.
AgOTf (0.0128 g, 0.05 mmol) was dissolved in MeCN (3 mL),
followed by addition of CHCl3 (15 mL). Complex 1 (0.0456 g,
Inorganic Chemistry, Vol. 42, No. 22, 2003 7295